Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.52 |
| ▸ | MGAM | O43451 | 1/20 | 0.52 |
| ▸ | SI | P14410 | 1/20 | 0.52 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.35 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9175497 | 0.97 | GAA (0.50) | GAAMGAMSIMGAM2TSHR | |
| SCHEMBL9177427 | 0.97 | GAA (0.50) | GAAMGAMSIMGAM2TSHR | |
| SCHEMBL8804004 | 0.84 | ALDH1A1 (0.45) | GAAMGAMSIMGAM2TSHR | |
| SCHEMBL9788303 | 0.83 | GAA (0.48) | GAAMGAMSIMGAM2TSHR | |
| SCHEMBL15099893 | 0.79 | ALDH1A1 (0.44) | GAAMGAMSIMGAM2TSHR | |
| SCHEMBL27331249 | 0.79 | TET2 (0.37) | GAAMGAMSIMGAM2TSHR | |
| SCHEMBL28290424 | 0.79 | MGAM (0.50) | GAAMGAMSIMGAM2TSHR | |
| SCHEMBL28290300 | 0.79 | MGAM (0.50) | GAAMGAMSIMGAM2TSHR | |
| SCHEMBL22647295 | 0.79 | GAA (0.44) | GAAMGAMSIMGAM2TSHR | |
| SCHEMBL9543 | 0.78 | TSHR (0.68) | GAAMGAMSIMGAM2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118758990-B | Narrowing photoinduced free radical ESR linewidth method applied to melting dynamic nuclear polarization | 中国科学院精密测量科学与技术创新研究院 | 2025-02-07 | — | — | CN | claimed |
| CN-118758990-A | Narrowing photoinduced free radical ESR linewidth method applied to melting dynamic nuclear polarization | 中国科学院精密测量科学与技术创新研究院 | 2024-10-11 | — | — | CN | claimed |
| CN-112062723-B | Preparation method of thiabendazole intermediate | 帕潘纳(北京)科技有限公司 | 2022-03-25 | — | — | CN | claimed |
| CN-112062723-A | Preparation method of thiabendazole intermediate | 帕潘纳(北京)科技有限公司 | 2020-12-11 | — | — | CN | claimed |
| US-20190119193-A1 | COMPOSITION FOR REGULATING PLANT GROWTH, METHOD FOR TREATING PLANTS THEREWITH, AND ACTIVE INGREDIENT THEREOF | Ivan Aleksandrovich Starikov | 2019-04-25 | — | — | US | claimed |
| EP-3473098-A1 | COMPOSITION FOR REGULATING PLANT GROWTH, METHOD FOR TREATING PLANTS THEREWITH, AND ACTIVE INGREDIENT THEREOF | Gorbunov, Sergei Valeryevich (RU) | 2019-04-24 | — | — | EP | claimed |
| EP-2948489-A1 | A POLYESTER POLYURETHANE MATERIAL WITH LONG TERM HYDROLYSIS RESISTANCE | Covestro Deutschland AG (DE) | 2015-12-02 | — | — | EP | claimed |
| US-20150322196-A1 | A POLYESTER POLYURETHANE MATERIAL WITH LONG TERM HYDROLYSIS RESISTANCE | BAYER MATERIALSCIENCE AG (DE) | 2015-11-12 | — | — | US | claimed |
| WO-2014114614-A1 | A POLYESTER POLYURETHANE MATERIAL WITH LONG TERM HYDROLYSIS RESISTANCE | BAYER MATERIALSCIENCE AG (DE) | 2014-07-31 | — | — | WO | claimed |
| WO-2013053665-A1 | POLYURETHANE, ITS PREPARATION PROCESS AND USES THEREOF | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2013-04-18 | — | — | WO | claimed |
| CN-118758990-B | Narrowing photoinduced free radical ESR linewidth method applied to melting dynamic nuclear polarization | 中国科学院精密测量科学与技术创新研究院 | 2025-02-07 | — | — | CN | disclosed |
| CN-118758990-A | Narrowing photoinduced free radical ESR linewidth method applied to melting dynamic nuclear polarization | 中国科学院精密测量科学与技术创新研究院 | 2024-10-11 | — | — | CN | disclosed |
| CN-114644565-B | Synthesis method of key intermediate of imidazolinone compound | 江苏中旗科技股份有限公司 | 2024-05-03 | — | — | CN | disclosed |
| CN-114702425-B | Process for the preparation of (S) -2-amino- (S) -3- [ pyrrolidone-2' ] alanine derivatives and intermediates | 苏州汉酶生物技术有限公司 | 2024-04-19 | — | — | CN | disclosed |
| CN-114644565-A | Synthesis method of key intermediate of imidazolone compound | 江苏中旗科技股份有限公司 | 2022-06-21 | — | — | CN | disclosed |
| US-3974278-A | 1,4-Dihydropyridine esters | BAYER AKTIENGESELLSCHAFT (DT) | 1976-08-10 | — | — | US | disclosed |
| US-3971796-A | 1,4-Dihydropyridine esters | BAYER AKTIENGESELLSCHAFT (DT) | 1976-07-27 | — | — | US | disclosed |
| US-3946028-A | HYPOTENSIVE AGENTS, CORONARY VESSEL DILATORS | BAYER AKTIENGESELLSCHAFT (DT) | 1976-03-23 | — | — | US | disclosed |
| US-3946027-A | HYPOTENSIVE AGENTS, CORONARY VESSEL DILATORS | BAYER AKTIENGESELLSCHAFT (DT) | 1976-03-23 | — | — | US | disclosed |
| US-3943140-A | HYPOTENSIVE, VASODILATION | BAYER AKTIENGESELLSCHAFT (DT) | 1976-03-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190119193-A1 | COMPOSITION FOR REGULATING PLANT GROWTH, METHOD FOR TREATING PLANTS THEREWITH, AND ACTIVE INGREDIENT THEREOF | OGDH, GOT1, OAT | GAA 480/4885MGAM 235/4885SI 93/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.